THBS3 Functions as a Novel Biomarker for Prognosis and Immunotherapeutic Response in Colorectal Cancer: An Integrative Analysis and Validation of the Thrombospondin Gene Family

Key Points

• THBS3 acts as a novel biomarker for prognosis in colorectal cancer, enhancing predictive capabilities for patient outcomes.
• Key evidence pointed to THBS3's significant role in therapeutic targeting and progression of CRC, with implications for treatment strategies.
• Integrative analysis highlighted the relevance of the thrombospondin gene family in understanding CRC mechanisms and potential interventions.
• The findings support the need for additional studies to explore the clinical utility of THBS3 in immunotherapy for colorectal cancer.